Skip to content

Length of Cook Catheter Placement and Induction of Labor

Length of Cook Catheter Placement and Induction of Labor: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04233008
Enrollment
178
Registered
2020-01-18
Start date
2019-01-01
Completion date
2020-07-01
Last updated
2022-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labor

Keywords

Maternal outcomes, Neonatal Outcomes

Brief summary

The goal of this study is to compare cook catheter placement for 6 vs. 12 hours to see if there is faster time to delivery for people admitted to labor and delivery undergoing induction of labor.

Detailed description

Upon presentation to labor and delivery the participant will have a cook catheter inserted digitally or by direct visualization with a speculum. The uterine component of the balloon will be inflated to maximum 60mL. The catheter will be taped to the inner thigh with gentle traction. In both groups participants will be started on hospital-based oxytocin protocol. This protocol beings with 2 milliunits/min of oxytocin, increasing by 2 milliunits every 15 minutes until regular uterine contractions occur. The maximum dose of oxytocin is considered to be 30 milliunits. The cook catheter will then be removed at 6 vs. 12 hours based on randomization. At that point health care providers will manage active labor. Health care providers many perform amniotomy at any point during the induction process with recommendation for amniotomy with cervix more than 4cm dilated. Labor interventions are at the discretion of the healthcare provider. The participants will have continuous fetal monitoring throughout their induction, labor and delivery. Need for operative delivery or cesarean section will be at the discretion of the health provider.

Interventions

DEVICEFoley catheter length

see arm description

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Women undergoing cervical ripening for labor induction at term (37-41 6/7 weeks) with a singleton gestation in cephalic presentation. Women will need to have a bishop score \<6 or cervical dilation \<2cm with intact membranes to be included.

Exclusion criteria

* Non English speaking * Contraindications to vaginal delivery * Prior cesarean section

Design outcomes

Primary

MeasureTime frameDescription
Time to DeliveryAssessed following delivery (delivery day, day 0)Time to delivery

Secondary

MeasureTime frameDescription
Maternal Length of StayAssessed at end of study period (week 4)Length of hospital stay from start of induction to postpartum discharge
Cesarean Delivery RateAssessed following delivery (delivery day, day 0)Cesarean delivery rate
Time to Active LaborAssessed following delivery (delivery day, day 0)Time to reaching active labor (defined as 5cm)
Delivery Within 12 HoursAssessed following delivery (delivery day, day 0)The number of women in each group who deliver within 12 hours
Indication for Cesarean DeliveryAssessed following delivery (delivery day, day 0)Number of Patient with Indication for Cesarean Delivery
Delivery Within 24 HoursAssessed following delivery (delivery day, day 0)The number of women in each group who deliver within 24 hours
Neonatal ComplicationsAssessed at end of study period (week 4)culture-proven neonatal sepsis, neonatal blood transfusion, hypoxic-ischemic encephalopathy, intraventricular hemorrhage grade 3 or 4, or therapeutic hypothermia
NICU AdmissionAssessed at end of study period (week 4)Number of infants admitted to NICU
NICU Admission >48 HoursAssessed at end of study period (week 4)Number of infants admitted to NICU for \>48 hours
Neonatal Length of StayAssessed at end of study period (week 4)Days of hospital stay
Maternal ComplicationsAssessed at end of study period (week 4)Estimated blood loss, blood transfusion, higher order laceration, endometritis, wound infection, venous thromboembolism, hysterectomy, ICU admission, maternal death

Countries

United States

Participant flow

Participants by arm

ArmCount
6 Hour Foley
Foley for up to 6 hours
89
12 Hour Foley
Foley up to 12 hours
88
Total177

Baseline characteristics

Characteristic6 Hour Foley12 Hour FoleyTotal
Age, Continuous31.2 years31.4 years31.3 years
Birthweight (g)3200 grams3149 grams3175 grams
Bishop score at randomization2 units on a scale2 units on a scale2 units on a scale
BMI30.1 kg/m231.8 kg/m231.0 kg/m2
Gestational Age39 Weeks39 Weeks39 Weeks
Nulliparous71 Participants68 Participants139 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian
8 Participants6 Participants14 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Black
16 Participants18 Participants34 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Latinx
20 Participants12 Participants32 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Race/Ethnicity
white
43 Participants52 Participants95 Participants
Sex: Female, Male
Female
89 Participants88 Participants177 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 890 / 890 / 890 / 89
other
Total, other adverse events
0 / 890 / 890 / 890 / 89
serious
Total, serious adverse events
0 / 890 / 890 / 890 / 89

Outcome results

Primary

Time to Delivery

Time to delivery

Time frame: Assessed following delivery (delivery day, day 0)

ArmMeasureValue (MEDIAN)
6 Hour FoleyTime to Delivery19.2 hours
12 Hour FoleyTime to Delivery24.3 hours
p-value: 0.04Wilcoxon (Mann-Whitney)
Secondary

Cesarean Delivery Rate

Cesarean delivery rate

Time frame: Assessed following delivery (delivery day, day 0)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyCesarean Delivery Rate17 Participants
12 Hour FoleyCesarean Delivery Rate25 Participants
p-value: 0.14Chi-squared
Secondary

Delivery Within 12 Hours

The number of women in each group who deliver within 12 hours

Time frame: Assessed following delivery (delivery day, day 0)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyDelivery Within 12 Hours14 Participants
12 Hour FoleyDelivery Within 12 Hours9 Participants
p-value: 0.39Chi-squared
Secondary

Delivery Within 24 Hours

The number of women in each group who deliver within 24 hours

Time frame: Assessed following delivery (delivery day, day 0)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyDelivery Within 24 Hours60 Participants
12 Hour FoleyDelivery Within 24 Hours42 Participants
p-value: <0.01Chi-squared
Secondary

Indication for Cesarean Delivery

Number of Patient with Indication for Cesarean Delivery

Time frame: Assessed following delivery (delivery day, day 0)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyIndication for Cesarean Delivery10 Participants
12 Hour FoleyIndication for Cesarean Delivery11 Participants
p-value: 0.8Chi-squared
Secondary

Maternal Complications

Estimated blood loss, blood transfusion, higher order laceration, endometritis, wound infection, venous thromboembolism, hysterectomy, ICU admission, maternal death

Time frame: Assessed at end of study period (week 4)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyMaternal ComplicationsHigher order laceration7 Participants
6 Hour FoleyMaternal ComplicationsEndometritis1 Participants
6 Hour FoleyMaternal ComplicationsWound infection1 Participants
6 Hour FoleyMaternal Complicationschorioamnionitis13 Participants
6 Hour FoleyMaternal ComplicationsPostpartum hemorrage7 Participants
12 Hour FoleyMaternal Complicationschorioamnionitis11 Participants
12 Hour FoleyMaternal ComplicationsHigher order laceration2 Participants
12 Hour FoleyMaternal ComplicationsPostpartum hemorrage8 Participants
12 Hour FoleyMaternal ComplicationsEndometritis1 Participants
12 Hour FoleyMaternal ComplicationsWound infection1 Participants
Secondary

Maternal Length of Stay

Length of hospital stay from start of induction to postpartum discharge

Time frame: Assessed at end of study period (week 4)

ArmMeasureValue (MEDIAN)
6 Hour FoleyMaternal Length of Stay2 days
12 Hour FoleyMaternal Length of Stay2 days
Secondary

Neonatal Complications

culture-proven neonatal sepsis, neonatal blood transfusion, hypoxic-ischemic encephalopathy, intraventricular hemorrhage grade 3 or 4, or therapeutic hypothermia

Time frame: Assessed at end of study period (week 4)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyNeonatal Complications0 Participants
12 Hour FoleyNeonatal Complications0 Participants
Secondary

Neonatal Length of Stay

Days of hospital stay

Time frame: Assessed at end of study period (week 4)

ArmMeasureValue (MEDIAN)
6 Hour FoleyNeonatal Length of Stay2 days
12 Hour FoleyNeonatal Length of Stay2 days
Secondary

NICU Admission

Number of infants admitted to NICU

Time frame: Assessed at end of study period (week 4)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyNICU Admission9 Participants
12 Hour FoleyNICU Admission6 Participants
Secondary

NICU Admission >48 Hours

Number of infants admitted to NICU for \>48 hours

Time frame: Assessed at end of study period (week 4)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
6 Hour FoleyNICU Admission >48 Hours4 Participants
12 Hour FoleyNICU Admission >48 Hours2 Participants
Secondary

Time to Active Labor

Time to reaching active labor (defined as 5cm)

Time frame: Assessed following delivery (delivery day, day 0)

ArmMeasureValue (MEDIAN)
6 Hour FoleyTime to Active Labor10.5 hours
12 Hour FoleyTime to Active Labor15.9 hours
p-value: <0.01Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026